AEHR
Aehr Test Systems
$98.40
▲ 27.2%Updated Today 3:42 PM ET
AEHR at a glance — five pillars scored 0–100 from real filed financials.
Overall: Unrated · 0/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
Market Cap
$0.00
P/E
—
Forward P/E (est.)
—
ROE
—
Revenue Growth
—
EPS Growth
—
Profit Margin
—
FCF Yield
—
Debt / Equity
—
ROIC
-3.0%
Interest Coverage
—
Current Ratio
10.97x
Dividend Yield
—
Implied Growth (rev. DCF)
—
Rating Score
0/100
Aehr Test Systems (AEHR) is a small-cap company in the Semiconductors industry, part of the Information Technology sector of the S&P 500.
In its latest reported year it generated about $58.97M in revenue and posted a net loss of $3.91M.
Our model rates AEHR Unrated (0/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Evidence of durable competitive advantage in the filed financials (10 years of history).
The numbers don't show a durable competitive advantage — margins, growth, or returns on capital have been unstable or thin. Great returns are still possible; they just aren't protected.
46.7% average over the last 3 years
±5.5 pts around 41.0% across 10 years
grew in 6 of the last 9 year-over-year periods
positive in 3 of 10 years
-3.0% latest fiscal year
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
4Y CAGR
37.3%
Revenue moved from $14.50M in 2016 to $58.97M in 2025, a 16.9% compound annual growth rate. The most recent year was roughly steady year over year. Slower, mature growth is common for established businesses.
Gross Margin
40.6%
Operating Margin
-9.6%
Net Margin
-6.6%
ROE
—
Total Debt
$0.00
Net Debt
-$36.91M
Net cash position
Net Debt / EBITDA
—
Debt / Equity
—
Leverage: debt-to-equity is n/a, with a current ratio of 11.0x. Detailed balance-sheet leverage is limited for this name. It carries roughly $0.00 of total debt against $36.91M of cash.
Operating CF
-$7.40M
Free Cash Flow
-$12.39M
FCF Margin
-21.0%
In the latest year Aehr Test Systems produced about -$7.40M of operating cash flow but negative free cash flow as it invested heavily. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
P/E
—
P/S
—
P/B
—
EV / EBITDA
—
AEHR trades at n/a trailing earnings. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.
Where AEHR sits versus its Information Technology sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 98 Information Technology companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How AEHR stacks up against its Information Technology peers — valuation, profitability, and growth versus the sector median.
In the Information Technology sector (230 S&P 500 companies), AEHR ranks #103 of 230 by our overall rating.
P/E vs sector
—
median 39.2x
ROE vs sector
—
median 17.5%
Growth vs sector
—
median 17.7%
Sector rank
#103
of 230 by rating
Peers are the closest Information Technology companies by sub-industry and size. Sector median is across all 230 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $98.40 today · expected CAGR -60% – -56%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $63.69M | $68.78M | $74.28M | $80.23M | $86.64M |
| Net income | $1.91M | $2.06M | $2.23M | $2.41M | $2.60M |
| EPS | $0.06 | $0.07 | $0.07 | $0.08 | $0.08 |
| Share price (low) | $0.73 | $0.79 | $0.85 | $0.92 | $0.99 |
| Share price (high) | $1.21 | $1.31 | $1.42 | $1.53 | $1.65 |
| CAGR (low–high) | -99% / -99% | -91% / -88% | -79% / -76% | -69% / -65% | -60% / -56% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for AEHR:
- As an established S&P 500 member in Information Technology, it brings scale and a long operating history.
The case against AEHR:
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Aehr Test Systems is a small-cap information technology business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Unrated (0/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 10 Wall Street analysts covering AEHR recommend (July 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more positive over the last three months (+10 pts of buy ratings).
Latest SEC Filings
AEHR's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
AEHR — frequently asked questions
Is AEHR a good stock to buy?
We don't give buy or sell advice. Review Aehr Test Systems's fundamentals, valuation, and 5-year financials on this page, then make your own decision — and consider a licensed professional.
Where does AEHR's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Aehr Test Systems's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for AEHR calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this AEHR analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell AEHR. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.